Health

The Polar Ignite 3 is a smartwatch with many features, including:

This document is a guideline for the detection of rubella. It introduces the general situation of rubella, general precautions for testing, serological testing, genetic testing, virus isolation, naming of detected viruses and references.

This document is the Weber Lab Biosafety Level 2 Manual. It outlines the safety precautions that must be followed when working with Listeria in the Weber Lab.

Kyushu Railway Memorial Hospital is a general hospital that provides a variety of medical services, including internal medicine, surgery, obstetrics and gynecology, and pediatrics. The hospital has advanced medical equipment and facilities and provides high-quality medical care.

This document is about pollen allergies. It introduces the symptoms, causes and treatments of pollen allergies.

This document describes how to use regional care conferences to promote regional integrated care.

CRC Group is a healthcare company that provides a variety of medical services, including clinical testing, food safety testing, and environmental testing.

This is an updated prospectus for the Xingquan Tiantianyi Money Market Fund. The fund is a money market fund with high liquidity and low risk. Its expected risk and expected return are lower than those of stock funds, hybrid funds and bond funds.

Suyin Finance Hengyuan Closed Bond 56th Term Financial Product Contract

This product is a columnar stool RNA extraction product with the characteristics of simple and fast operation, good decontamination effect and high RNA purity.

The SM800 ELISA Reader Manual introduces the usage and precautions of the SM800 ELISA Reader.

This document is a guide to overseas travel insurance, which introduces the insurance coverage and claims procedures.

This document is a code of professional conduct for registered medical practitioners in Hong Kong.

This wealth management product is a non-保本浮动收益型产品, with a performance comparison benchmark of 5.15%. The product was established on November 25, 2016 and will mature on December 9, 2021.

The invention discloses a plant essential oil for preventing and controlling tsutsugamushi disease caused by a new species of Leptotrombidium, which comprises the following components in parts by weight: 2-20 parts of thymol, 1-10 parts of eugenol, 1-10 parts of methyl eugenol, 0-15 parts of apiol, 1-20 parts of cinnamaldehyde, 0.1-2 parts of sanguinarine and 0.1-2 parts of hypericin. According to the characteristics of various plant essential oils, the present invention screens out the optimal proportion for tsutsugamushi disease caused by a new species of Leptotrombidium in chickens;复配由多种植物精油进行复配，并具有非常好的抗菌效果，而 且百里香酚和肉桂醛的质量比为5：1时有显著的 协同增效作用，使药物安全、绿色、高效，无毒副 作用和无抗药性，无残留，无配伍禁忌。